News

Corona/COVID 19 - INNO4COV-19 - "Innovation hub" project (1st deadline on 30 November 2020)

Published on | 4 years ago

Programmes ICT NMBP Health

INNO4COV-19 OPEN CALL - Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance

Are you working for a company active in healthcare,  medicine, biotech, biopharma, and/or IT-related topics (e.g. robotics, automation, electronics, nanotech, etc)? Then have a look at this accessible funding scheme (up to 100k€ subsidy). 

Submission deadlines in November 2020, March 2021 and May 2021.

INNO4COV-19 at a Glance

Create a “lab-to-fab” platform and collaboration resource to enable companies and reference laboratories to develop and implement innovative technologies to fight COVID-19.

Website: www.inno4cov19.eu

The INNO4COV-19 Project aims to support the full development to market uptake of technologies at TRL6-7 or higher. It Provides funding to third parties to archive the desiderated objectives.

Eligibility criteria

  • Companies or small consortia of companies established in one of the EU Member States or H2020 associated countries.
  • The sectors of focus may include healthcare / medicine / biotech / biopharma, and IT-related topics (e.g. robotics, automation, electronics, nanotech, etc).

What they offer

  • Financial support - Up to EUR 100,000 (100% of the total cost of the project)
  • Tailored support - Guidance from a network of experts at a technical, business and regulatory level for bringing your innovation to the market
  • Access to specific facilities and infrastructure - Providing added value to your innovations
  • Media exposure - Highlights through our network

Key dates

The applications will be considered in three different rounds.

  • NOVEMBER 2020 ROUND - Deadline: 30/11/2020 – Funding decision: +40days
  • MARCH 2021 ROUND - Deadline: 31/03/2021 – Funding decision: +40days
  • May 2021 ROUND - Deadline: 31/05/2021 – Funding decision: +40days

More information on the website of the call: www.inno4cov19.eu/open-call

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1745 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.